We use cookies on this website. By continuing to use this site without changing your cookie settings, you agree that you are happy to accept our cookies and for us to access these on your device. Find out more about how we use cookies and how to change your cookie settings.

Reversal of autism-like disorder

19 February 2008

Reversal of an autism-like disorder
Studies in mice suggest that autism-like conditions may be reversible.

Rett syndrome is an autism-like disorder caused by the mutation of a single gene - MECP2. Although the function of nerve cells is clearly affected, they do not die as in neurodegenerative conditions such as Alzheimer’s. A key question, then, is: can the brain’s developmental abnormalities be reversed? Working with a mouse model, Professor Adrian Bird and colleagues at the University of Edinburgh have uncovered remarkable evidence that they can.

Professor Bird’s team has been studying the MECP2 gene for several years. It encodes a protein that regulates the activity of other genes. Mutations in the gene affect around 1 in 10 000 girls, and causes distressing physical symptoms, including loss of movement, abnormal breathing patterns and difficulty with speech. Many children display an abnormal, stiff-legged gait and some become confined to a wheelchair.

Professor Bird’s team created a mouse model of this disease by silencing the expression of MECP2. To their surprise, the Rett-like symptoms these mice developed disappeared when the gene was reactivated.

This implies that the effects of the Rett syndrome mutation are not permanently wired into the brain. If this is also true in people, it might be possible to reverse the symptoms of Rett syndrome by reactivating the MECP2 gene (although the approach used in mice is not one applicable to people).

More generally, the study raises hopes that a range of human neurodevelopmental disorders might be reversible.

Further reading

Share |
Home  >  About us  >  Publications  >  Annual Review  >  Previous  >  2007  > Reversal of an autism-like disorder
Wellcome Trust, Gibbs Building, 215 Euston Road, London NW1 2BE, UK T:+44 (0)20 7611 8888